(PharmaNewsWire.Com, January 31, 2017 ) According to Publisher, the Global Epigenetics market is accounted for $500 million in 2015 and is expected to reach $1,286 million by 2022 growing at a CAGR of 14.4% from 2015 to 2022. Growing prevalence of cancer and other chronic diseases are helping the market to compete across the globe. Some of the major factors that are influencing the market include growing technological advancements, improving collaborations between pharmaceutical companies, biotechnology companies and academic research institutes and increasing geriatric population base. However, huge equipment cost and shortage of skilled professional are hampering the market.
By oncology application, solid tumors accounted for the largest market share during the forecast period. Moreover, cardiovascular diseases segment is observed as the fastest growing market attributed to emergence of technologies such as microRNA modifications. North America commanded the largest market share owing to growing R&D activities in pharmaceuticals firms.
Some of the key players in this market include Zymo Research Corporation, Sigma-Aldrich Corporation, New England Biolabs, Illumina, Inc., Active Motif, Thermo Fisher Scientific, Inc, Qiagen N.V., Merck & Co., Inc., Diagenode, Inc. and Abcam PLC.
Products Covered: - Reagents o Primers o Histones o Antibodies o Magnetic Beads o Buffers o Other Epigenetics Reagents - Instruments and Consumables o Sonicators o Next-Generation Sequencers o QPCR o Mass Spectrometers o Other Epigenetics Instruments and Consumables - Enzymes o Rna-Modifying Enzymes o DNA-Modifying Enzymes o Protein-Modifying Enzymes - KITS o Chip-Seq KITS o Whole-Genome Amplification KITS o Bisulfite Conversion KITS o Rna Sequencing KITS o 5-HMC and 5-MC Analysis KITS o Other Epigenetics KITS
Application Covered: - Non-oncology Disorders o Inflammatory Diseases o Cardiovascular Diseases o Metabolic Diseases o Other Non-oncology Disorders - Oncology o Solid Tumors o Liquid Tumors
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
10 Company Profiling 10.1 Zymo Research Corporation 10.2 Sigma-Aldrich Corporation 10.3 New England Biolabs 10.4 Illumina, Inc. 10.5 Active Motif 10.6 Thermo Fisher Scientific, Inc. 10.7 Qiagen N.V. 10.8 Merck & Co., Inc. 10.9 Diagenode, Inc. 10.10 Abcam PLC
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
